Wandering in dementia (WANDA) – a systematic review of interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use
Study Code / Acronym
WANDAAward Number
03/16/04Programme
Health Technology AssessmentStatus / Stage
CompletedDates
1 March 2004 -1 April 2005
Duration (calculated)
01 years 01 monthsFunder(s)
NIHRFunding Amount
£124,900.00Funder/Grant study page
NIHRContracted Centre
University of Newcastle upon TynePrincipal Investigator
Professor Dame Louise RobinsonPI Contact
a.l.robinson@ncl.ac.ukWHO Catergories
Risk reduction interventionTools and methodologies for interventions
Disease Type
Dementia (Unspecified)CPEC Review Info
Reference ID | 57 |
---|---|
Researcher | Reside Team |
Published | 12/06/2023 |
Data
Study Code / Acronym | WANDA |
---|---|
Award Number | 03/16/04 |
Status / Stage | Completed |
Start Date | 20040301 |
End Date | 20050401 |
Duration (calculated) | 01 years 01 months |
Funder/Grant study page | NIHR |
Contracted Centre | University of Newcastle upon Tyne |
Funding Amount | £124,900.00 |
Abstract
Wandering is a common problem in dementia occurring in up to 40% of people. The term ‘wandering’ refers to a complex collection of different behavioural abnormalities which occur for a multitude of reasons. Traditional responses to wandering include physical barriers (alarms, locks), human and physical restraints (Buxton chairs, tethers), and medication (neuroleptic). More recent interventions include electronic devices that increase freedom and autonomy while minimising risk (electronic tagging and tracking), behavioural approaches (such as cognitive behavioural therapy), and distraction therapies (such as physical activity and planned walks, music therapy, occupational therapy). Subjective barriers (visual modifications that the person with dementia may interpret as a barrier even if it is not physically so e.g. painted bars on windows), were the subject of a recent Cochrane review which found no suitable trials from which to comment on their effectiveness. A systematic review is therefore required to synthesise the evidence for the other non-pharmacological interventions listed above. This project aims to determine the clinical and cost effectiveness of non-drug related interventions to prevent/reduce wandering in people with dementia, and to assess their acceptability to relevant stakeholders, through a systematic review. If the available evidence on cost effectiveness is too limited or of unsatisfactory quality, the economic evaluation will include a simulation modelling exercise. Outcomes will include the number of successful/attempted exits, number and nature of accidents, acceptability measures for both patients and carers, quality of life measures and assessment of costs of care. The project will also consider in greater depth the acceptability and ethical implications of such interventions through a qualitative study of relevant stakeholders, such as people with dementia, their informal and formal carers and health and social care professionals via focus groups and one to one interviews.
Aims
This project aims to determine the clinical and cost effectiveness of non-drug related interventions to prevent/reduce wandering in people with dementia, and to assess their acceptability to relevant stakeholders, through a systematic review.